62 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
, with the remainder vesting in equal monthly installments for the three years thereafter.
Each PSU vests upon satisfaction of four escalating ADS price threshold
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
satisfaction of a milestone. Feng Biosciences will be responsible for all future research, development and commercialization of Navi. Additionally, we … have been met to the FDA’s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing
10-K
2023 FY
EX-10.30
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
following satisfaction of the conditions to payment set forth in this Section 4.2 by ReproNovo, its Affiliates or their Sublicensees. The Parties
10-K
2023 FY
EX-4.2
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
meeting declaring a dividend may by ordinary resolution of shareholders, upon the recommendation of the board, direct payment or satisfaction … as the depositary may deem reasonably appropriate, subject however, in each case, to satisfaction of the applicable registration requirements
6-K
EX-3.1
MREO
Mereo Biopharma Group Plc
18 Dec 23
Current report (foreign)
4:10pm
against that person;
a composition is made with that person’s creditors generally in satisfaction of that person’s debts or any analogous event occurs … person authorised in that behalf by that court, and any such person may vote by proxy. Evidence to the satisfaction of the Directors of the authority
6-K
1eapb81jo1vlt4wrjyrp
20 Sep 23
Current report (foreign)
4:03pm
6-K
EX-99.2
up7sicwp sm2stfjsc
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
6-K
EX-3.1
pgdpox
17 May 22
Current report (foreign)
8:26am
F-3/A
xbdih
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
F-3/A
zabo7mhj
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
93kkklkv16m5ueetk
5 Aug 21
Shelf registration (foreign)
4:33pm
F-3
EX-1.2
posqedio270j
5 Aug 21
Shelf registration (foreign)
4:33pm
6-K
EX-1.1
h1423pvw 1d70
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
6-K
9l1c6ww f2ypkfgf9pve
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
6-K
EX-99.2
4j0xtvw8 kt9aqt
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
424B5
ivylmezod79xq5p44
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
3mo8jil
9 Feb 21
Prospectus supplement for primary offering
5:24pm